• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙醇和热消融治疗甲状腺恶性肿瘤。

Ethanol and thermal ablation for malignant thyroid tumours.

机构信息

a Department of Radiology and Research Institute of Radiology , University of Ulsan College of Medicine, Asan Medical Center , Seoul , Korea.

出版信息

Int J Hyperthermia. 2017 Dec;33(8):938-945. doi: 10.1080/02656736.2017.1361048. Epub 2017 Aug 11.

DOI:10.1080/02656736.2017.1361048
PMID:28797186
Abstract

Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid malignancy and has a good prognosis and low mortality rate. Surgery is the standard treatment for patients with primary and recurrent thyroid cancer. Although patients with PTC usually exhibit excellent treatment outcome, the incidence of recurrence in the neck ranges from 20% to 59%. When a patient with thyroid cancer is contraindicated for surgery, ultrasound (US)-guided ablation techniques, including ethanol ablation (EA) and thermal ablations, are suggested alternatives. In this review, we evaluated the indications, devices, techniques, clinical outcomes, and complications associated with US-guided EA and thermal ablations based on available scientific evidence and expert opinions regarding the use of ablation for primary and recurrent thyroid cancers.

摘要

甲状腺乳头状癌(PTC)是甲状腺恶性肿瘤中最常见的亚型,具有良好的预后和较低的死亡率。手术是治疗原发性和复发性甲状腺癌患者的标准方法。尽管 PTC 患者通常表现出良好的治疗效果,但颈部复发的发生率为 20%至 59%。当甲状腺癌患者不适合手术时,超声(US)引导下的消融技术,包括乙醇消融(EA)和热消融,是建议的替代方法。在本综述中,我们根据现有的科学证据和专家意见,评估了 US 引导下 EA 和热消融在原发性和复发性甲状腺癌中的适应证、设备、技术、临床结果和并发症。

相似文献

1
Ethanol and thermal ablation for malignant thyroid tumours.乙醇和热消融治疗甲状腺恶性肿瘤。
Int J Hyperthermia. 2017 Dec;33(8):938-945. doi: 10.1080/02656736.2017.1361048. Epub 2017 Aug 11.
2
Efficacy and Safety of Radiofrequency and Ethanol Ablation for Treating Locally Recurrent Thyroid Cancer: A Systematic Review and Meta-Analysis.射频消融和乙醇消融治疗局部复发性甲状腺癌的疗效和安全性:系统评价和荟萃分析。
Thyroid. 2016 Mar;26(3):420-8. doi: 10.1089/thy.2015.0545. Epub 2016 Feb 10.
3
Surgical Confirmation of Incomplete Treatment for Primary Papillary Thyroid Carcinoma by Percutaneous Thermal Ablation: A Retrospective Case Review and Literature Review.经皮热消融治疗原发性甲状腺乳头状癌不完全治疗的手术确认:回顾性病例分析及文献复习。
Thyroid. 2018 Sep;28(9):1134-1142. doi: 10.1089/thy.2017.0558. Epub 2018 Aug 14.
4
Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma: A Prospective Study.超声引导下射频消融治疗低危甲状腺微小乳头状癌的疗效与安全性:一项前瞻性研究
Thyroid. 2016 Nov;26(11):1581-1587. doi: 10.1089/thy.2015.0471. Epub 2016 Aug 18.
5
Image-guided chemical and thermal ablations for thyroid disease: Review of efficacy and complications.甲状腺疾病的影像引导化学和热消融治疗:疗效和并发症的综述。
Head Neck. 2018 Sep;40(9):2103-2115. doi: 10.1002/hed.25181. Epub 2018 Apr 23.
6
Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges.射频消融和乙醇消融治疗复发性甲状腺癌:现状与挑战。
Curr Opin Oncol. 2013 Jan;25(1):14-9. doi: 10.1097/CCO.0b013e32835a583d.
7
Laser and radiofrequency ablations for benign and malignant thyroid tumors.激光和射频消融治疗良性和恶性甲状腺肿瘤。
Int J Hyperthermia. 2019 Oct;36(2):13-20. doi: 10.1080/02656736.2019.1622795.
8
[Expert consensus on thermal ablation of papillary thyroid cancer (2024 edition)].《甲状腺乳头状癌热消融专家共识(2024年版)》
Zhonghua Nei Ke Za Zhi. 2024 Apr 1;63(4):355-364. doi: 10.3760/cma.j.cn112138-20231104-00296.
9
Radiofrequency ablation of recurrent thyroid cancers: anatomy-based management.复发性甲状腺癌的射频消融:基于解剖学的管理
Ultrasonography. 2022 Jul;41(3):434-443. doi: 10.14366/usg.21221. Epub 2021 Dec 21.
10
Thermal Ablation for Small Papillary Thyroid Cancer: A Systematic Review.甲状腺微小乳头状癌的热消融治疗:系统评价。
Thyroid. 2019 Dec;29(12):1774-1783. doi: 10.1089/thy.2019.0377. Epub 2019 Dec 6.

引用本文的文献

1
Ablative Therapies in Low-Risk Thyroid Cancer.低风险甲状腺癌的消融治疗
Ann Surg Oncol. 2025 May 29. doi: 10.1245/s10434-025-17498-0.
2
OK-432 (Picibanil) Sclerotherapy for the Treatment of Chyle Leakage After Thyroid Surgery.OK-432(沙培林)硬化疗法治疗甲状腺切除术后乳糜漏
Korean J Radiol. 2025 Jul;26(7):727-733. doi: 10.3348/kjr.2025.0230. Epub 2025 Apr 29.
3
Brazilian Consensus on the Application of Thermal Ablation for Treatment of Thyroid Nodules: A Task Force Statement by the Brazilian Society of Interventional Radiology and Endovascular Surgery (SOBRICE), Brazilian Society of Head and Neck Surgery (SBCCP), and Brazilian Society of Endocrinology and Metabolism (SBEM).
巴西甲状腺结节热消融治疗应用共识:巴西介入放射学和血管外科学会(SOBRICE)、巴西头颈外科学会(SBCCP)和巴西内分泌代谢学会(SBEM)联合发布的专家声明
Arch Endocrinol Metab. 2024 Jun 24;68:e230263. doi: 10.20945/2359-4292-2023-0263. eCollection 2024.
4
Effectiveness of microvascular flow imaging for radiofrequency ablation in recurrent thyroid cancer: comparison with power Doppler imaging.微血管血流成像在复发性甲状腺癌射频消融中的有效性:与能量多普勒成像的比较
Eur Radiol. 2025 Feb;35(2):597-607. doi: 10.1007/s00330-024-10977-0. Epub 2024 Jul 23.
5
Can Ethanol Ablation Achieve Durable Control of Neck Nodal Recurrences in Adults With Stage I Papillary Thyroid Cancer?乙醇消融能否持久控制I期成人乳头状甲状腺癌颈部淋巴结复发?
J Endocr Soc. 2024 Feb 27;8(5):bvae037. doi: 10.1210/jendso/bvae037. eCollection 2024 Mar 12.
6
Ultrasound-guided radiofrequency ablation for the treatment of papillary thyroid carcinoma: a review of the current state and future perspectives.超声引导下射频消融治疗甲状腺乳头状癌:现状与未来展望综述
Ultrasonography. 2024 Mar;43(2):79-87. doi: 10.14366/usg.23091. Epub 2023 Dec 11.
7
Improving Voice Outcomes after Thyroid Surgery and Ultrasound-Guided Ablation Procedures.改善甲状腺手术及超声引导下消融术后的嗓音效果。
Front Surg. 2022 May 4;9:882594. doi: 10.3389/fsurg.2022.882594. eCollection 2022.
8
Radiofrequency ablation of recurrent thyroid cancers: anatomy-based management.复发性甲状腺癌的射频消融:基于解剖学的管理
Ultrasonography. 2022 Jul;41(3):434-443. doi: 10.14366/usg.21221. Epub 2021 Dec 21.
9
Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis.长链非编码 RNA ROR 通过调节 TESC/ALDH1A1/TUBB3/PTEN 轴促进甲状腺乳头状癌的进展。
Cell Death Dis. 2022 Feb 16;13(2):157. doi: 10.1038/s41419-021-04210-9.
10
Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.甲状腺微小乳头状癌:基于临床和超声特征的列线图,以提高中央区淋巴结转移的预测准确性。
Front Endocrinol (Lausanne). 2022 Jan 12;12:770824. doi: 10.3389/fendo.2021.770824. eCollection 2021.